MedPath

The Prone to Supine Breast MRI Trial

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Other: Prone to Supine MRI
Registration Number
NCT03573804
Lead Sponsor
Dartmouth-Hitchcock Medical Center
Brief Summary

The purpose of this study is to determine whether a supine MRI obtained immediately after a standard diagnostic prone MRI exam, without a second injection of gadolinium (Gd) contrast material, would be of sufficient quality to allow the Radiologist to define the tumor edges ("segment" the tumor) so that a 3-D image of the tumor can be generated to form a BCL.

Detailed Description

The purpose of this study is to find out whether additional MRI images taken with patients in a different position after completing a standard MRI are of sufficient quality to allow a radiologist to identify the edges of the tumor.

These additional MRI images will only take about 10-15 minutes to obtain and will not require a second injection of contrast material.The information gathered in this study will make it more feasible to use a new device called the "breast cancer locator" to help surgeons more accurately remove breast cancers.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
72
Inclusion Criteria
  • Age > 18 years.
  • Female gender.
  • Histologic diagnosis of invasive breast cancer or ductal carcinoma in situ
  • Tumor size at least 1 cm in diameter as visualized on mammogram or US.
  • A diagnostic breast MRI is considered to be clinically indicated.
  • Ability to voluntarily provide informed consent to participate prior to any study-related assessments/procedures being conducted.
Exclusion Criteria
  • Absolute contraindication to MRI, including presence of implanted electrical device (pacemaker or neurostimulator), aneurysm clip, or metallic foreign body in or near eyes.
  • Severe claustrophobia.
  • Contraindication to use of gadolinium-based intravenous contrast, including life- threatening allergy or compromised renal function (eGFR < 30 ml/min/1.73m2).
  • History of median sternotomy.
  • Pregnancy. Patient attestation that they are not pregnant will be acceptable.
  • Patients who have received neoadjuvant chemotherapy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Prone to Supine MRIProne to Supine MRIThe patient will be placed in the prone position and undergo a standard Gd contrast-enhanced bilateral breast MRI. Immediately after the prone MRI is completed, the patient will be repositioned for the supine MRI. Prior to starting the prone MRI, the study MRI technician/investigator will explain to the patient and practice with the patient the steps needed to transition from the prone to the supine MRI, so as to facilitate a timely transition. Additional MRI images will only take about 10-15 minutes to obtain and will not require a second injection of contrast material.
Primary Outcome Measures
NameTimeMethod
Number of Successful Segmentation of Supine MRI Images30 minutes

Determine what number of cases that can be successfully segmented both from using post-contrast prone MRI images and also from using post contrast supine MRI images.

Secondary Outcome Measures
NameTimeMethod
Time to Position and Obtain Supine Images30 Minutes

Calculate the additional time needed to obtain supine MRI images. After the completion of Prone imaging, the patient was removed from the MRI, turned over to the supine position, new coils placed, and returned to the MRI for additional imaging. The aggregate time to accomplish these tasks are noted in minutes.

Enhancement Quantification, as Measured by Signal Intensity - Segmented Tumor30 minutes

Compare the signal intensity with that obtained at tumor location on the prone and supine imaging. The amount of enhancement at the tumor site = segmented tumor.

Enhancement Quantification- Tumor-to-Background Ratio30 minutes

Mean MRI signal of the segmented tumor divided by the mean MRI signal of the surrounding tissue which has an equal volume to the tumor. The difference between tumor and benign breast tissue is the tumor-to-background ratio

Enhancement Quantification, as Measured by Signal Intensity - Tumor Boundary30 minutes

Compare the signal intensity with that obtained in benign tissue surrounding the tumor on the prone and supine imaging.

Overall Comfort for Prone and Supine PositionsWithin 15 minutes of the scan

Quantify the perceived comfort level of the prone and supine MRI as reported by participants. A single question using a Likert scale was was used. The scale range was 0 to 5, where 0 = no pain, completely comfortable and 5 = considerable discomfort.

Trial Locations

Locations (1)

Dartmouth Hitchcock Medical Center

🇺🇸

Lebanon, New Hampshire, United States

© Copyright 2025. All Rights Reserved by MedPath